Provided by Tiger Trade Technology Pte. Ltd.

Aligos Therapeutics, Inc.

5.50
-0.1300-2.31%
Post-market: 5.500.00000.00%19:30 EDT
Volume:28.26K
Turnover:158.13K
Market Cap:34.35M
PE:-0.75
High:5.74
Open:5.69
Low:5.37
Close:5.63
52wk High:13.69
52wk Low:3.98
Shares:6.24M
Float Shares:3.68M
Volume Ratio:0.61
T/O Rate:0.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.3016
EPS(LYR):-2.4500
ROE:-113.59%
ROA:-49.12%
PB:1.08
PE(LYR):-2.24

Loading ...

Mar 09, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 27, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 02, 2022

Major Issues Report

8-K - Current report
Nov 02, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 27, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 30, 2022

Major Issues Report

8-K - Current report
Mar 22, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]